DE602007008385D1 - Verwendung von valproinsäure zur topischen behandlung von leichter bis mittelschwerer akne vulgaris - Google Patents

Verwendung von valproinsäure zur topischen behandlung von leichter bis mittelschwerer akne vulgaris

Info

Publication number
DE602007008385D1
DE602007008385D1 DE602007008385T DE602007008385T DE602007008385D1 DE 602007008385 D1 DE602007008385 D1 DE 602007008385D1 DE 602007008385 T DE602007008385 T DE 602007008385T DE 602007008385 T DE602007008385 T DE 602007008385T DE 602007008385 D1 DE602007008385 D1 DE 602007008385D1
Authority
DE
Germany
Prior art keywords
vpa
acne vulgaris
valproic acid
medium
light
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007008385T
Other languages
German (de)
English (en)
Inventor
Bernd Hentsch
Sylvia E Schwarz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Topotarget Germany AG
Original Assignee
Topotarget Germany AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Topotarget Germany AG filed Critical Topotarget Germany AG
Publication of DE602007008385D1 publication Critical patent/DE602007008385D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
DE602007008385T 2006-03-31 2007-03-13 Verwendung von valproinsäure zur topischen behandlung von leichter bis mittelschwerer akne vulgaris Active DE602007008385D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06006847A EP1839656A1 (en) 2006-03-31 2006-03-31 Use of valproic acid for the topical treatment of mild to moderate acne vulgaris
PCT/EP2007/002201 WO2007112832A1 (en) 2006-03-31 2007-03-13 Use of valproic acid for the topical treatment of mild to moderate acne vulgaris

Publications (1)

Publication Number Publication Date
DE602007008385D1 true DE602007008385D1 (de) 2010-09-23

Family

ID=36498743

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007008385T Active DE602007008385D1 (de) 2006-03-31 2007-03-13 Verwendung von valproinsäure zur topischen behandlung von leichter bis mittelschwerer akne vulgaris

Country Status (6)

Country Link
US (1) US20090186809A1 (enExample)
EP (2) EP1839656A1 (enExample)
JP (1) JP2009534306A (enExample)
AT (1) ATE476972T1 (enExample)
DE (1) DE602007008385D1 (enExample)
WO (1) WO2007112832A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8492438B2 (en) * 2002-04-26 2013-07-23 Asan Laboratories Company (Cayman), Limited Treatment skin disorders
EP1491188A1 (en) * 2003-06-25 2004-12-29 G2M Cancer Drugs AG Topical use of valproic acid for the prevention or treatment of skin disorders
US20080213399A1 (en) 2005-02-03 2008-09-04 Topotarget Uk Limited Combination Therapies Using Hdac Inhibitors
CA2606598C (en) * 2005-05-13 2014-12-23 Topotarget Uk Limited Pharmaceutical formulations of hdac inhibitors
CA2627923C (en) * 2005-11-10 2016-01-12 Topotarget Uk Limited Histone deacetylase (hdac) inhibitors (pxdlol) for the treatment of cancer
CA2700173C (en) * 2007-09-25 2016-10-11 Topotarget Uk Limited Methods of synthesis of certain hydroxamic acid compounds
ES2536208T3 (es) * 2008-03-07 2015-05-21 Onxeo Dk, Branch Of Onxeo S.A., France Métodos de tratamiento que emplean infusión continua prolongada de Belinostat
AU2009333588A1 (en) 2008-12-08 2011-07-21 Northwestern University Method of modulating HSF-1
GB0900555D0 (en) * 2009-01-14 2009-02-11 Topotarget As New methods
EP2531186B1 (en) * 2010-02-05 2016-07-20 Sunny Pharmtech Inc., Treatment of rosacea with 4-phenylbutyrate
KR101733189B1 (ko) * 2010-10-06 2017-05-08 (주)아모레퍼시픽 손톱 또는 발톱 성장 촉진용 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1491188A1 (en) * 2003-06-25 2004-12-29 G2M Cancer Drugs AG Topical use of valproic acid for the prevention or treatment of skin disorders
EP1591109B1 (en) * 2004-04-30 2008-07-02 TopoTarget Germany AG Formulation comprising histone deacetylase inhibitor exhibiting biphasic release
NZ552758A (en) * 2004-07-28 2009-08-28 Janssen Pharmaceutica Nv Substituted propenyl piperazine derivatives as inhibitors of histone deacetylase

Also Published As

Publication number Publication date
WO2007112832A1 (en) 2007-10-11
JP2009534306A (ja) 2009-09-24
EP1839656A1 (en) 2007-10-03
US20090186809A1 (en) 2009-07-23
ATE476972T1 (de) 2010-08-15
EP2001458B1 (en) 2010-08-11
EP2001458A1 (en) 2008-12-17

Similar Documents

Publication Publication Date Title
DE602007008385D1 (de) Verwendung von valproinsäure zur topischen behandlung von leichter bis mittelschwerer akne vulgaris
EA200970791A1 (ru) N-АДАМАНТИЛБЕНЗАМИДЫ В КАЧЕСТВЕ ИНГИБИТОРОВ 11-β-ГИДРОКСИСТЕРОИДДЕГИДРОГЕНАЗЫ
WO2008101907A3 (en) N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
CY1116464T1 (el) Θεραπεια συνδυασμου για τη θεραπευτικη αγωγη διαταραχων ανεπαρκειας πρωτεϊνης
BRPI0414581A (pt) derivados de benzimidazol: preparação e aplicações farmacêuticas
EA200801492A1 (ru) Фармацевтическое применение замещенных амидов
WO2007144394A3 (en) Pharmaceutical use of substituted piperidine carboxamides
ATE467616T1 (de) Verbindungen mit aktivität an der 11beta- hydroxasteroiddehydrogenase
WO2002007722A3 (en) Valproic acid and derivatives thereof as histone deacetylase inhibitors
ATE469674T1 (de) 5-aminolävulinsäure-derivate zur behandlung von akne
WO2001039759A3 (en) Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
WO2023078333A8 (zh) 一种取代的苯丙酸衍生物及其用途
NO20005912L (no) Sulfonylsyre- eller sulfonylamino-N-(heteroaralkyl)- azaheterocyklylamidforbindelser
TW200719882A (en) Treatment of connective tissue diseases of the skin
DE502004008819D1 (de) Medikament zur wachstumsinhibierung von tumoren
BR112014002885A2 (pt) uso de composto orgânico para o tratamento da síndrome de noonan
RU2008127882A (ru) Лечение пищевода барретта
BRPI0415628A (pt) suspensões analgésicas para liberação controlada
NO20070250L (no) S-Tenatoprazol-natriummonohydratsalt og dennes anvendelse i form av en protonpumpe-inhibitor
BRPI0415630A (pt) suspensões analgésicas para liberação controlada
WO2006065870A3 (en) Topical numbing composition for laser therapy
EE200200549A (et) Jagatud doosi teraapia veresooni kahjustava aktiivsusega
ATE516038T1 (de) Metallcluster-nanoverbindungen zur behandlung von tumorerkrankungen
BR0307039A (pt) Compostos, em particular de derivados uréias ou ésteres do ácido haloacetamidobenzóico e sua utilização para o tratamento de doenças parasitárias
NO20054320L (no) Terapeutisk middel mot hemoroidesykdom